| HOME >> BIOLOGY >> TECHNOLOGY |
Kathy Lang Joins from Auxilium Pharmaceutical as Director, Trade Relations
PARSIPPANY, N.J., Sept. 25 /PRNewswire/ -- Valeritas, LLC, a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that it has hired Kathy Lang to serve as Director of Trade Relations.
Ms. Lang will join the Integrated Healthcare Management Team reporting directly to Matt Nguyen, PharmD. She will play a critical role in developing and executing a trade strategy for Valeritas products in the metabolism arena, with her near term focus on the h-Patch(TM), a once-daily, disposable insulin delivery device that is scheduled for a regional launch in Q1 2008. Ms. Lang will be responsible for managing contracted distribution vendor relationships and services between Valeritas customers and supply chain partners, and will also serve as the primary liaison with pharmacy and trade associations and data sourcing companies. Her additional responsibilities include overseeing/managing inventory issues to ensure adequate product levels are maintained at all times.
As the key driver behind the development of Valeritas' trade strategy, Ms. Lang will play a critical role in the launch of h-Patch(TM).
"Kathy's reputation and experience in the industry is second-to-none," said Robert Gonnelli, President and CEO of Valeritas. "Her past experiences and successes have shown that she has the strategic insight to solidify and validate our approach to managing the h-Patch(TM) distribution through wholesalers."
"I am honored to be part of such an exciting launch of this
first-in-class, once-daily disposable insulin delivery device -- which was
designed with simplicity-of-use for the end user in mind," said Ms. Lang.
"The distribution of the h-Patch(TM) through the traditional pharmacy
channel will allow for patients to fulfill their prescription conveniently
and to maintain continued compliance of their insul
'/>"/>
| SOURCE Valeritas, LLC Copyright©2007 PR Newswire. All rights reserved |